O'Neil Wiggan

Title: O'Neil Wiggan: Innovator in Live Attenuated Virus Research

Introduction

O'Neil Wiggan is a notable inventor based in Fort Collins, CO (US). He has made significant contributions to the field of virology, particularly in the development of live attenuated virus compositions. With a total of 5 patents to his name, Wiggan's work has the potential to impact vaccine development and viral research.

Latest Patents

Wiggan's latest patents focus on methods and compositions for live attenuated viruses. These embodiments relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. Additionally, some compositions may include at least one carbohydrate, at least one protein, and at least one high molecular weight surfactant for reducing inactivation and/or degradation of the live, attenuated virus.

Career Highlights

Throughout his career, O'Neil Wiggan has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Takeda Vaccines, Inc. and Inviragen, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative vaccine solutions.

Collaborations

Wiggan has collaborated with several esteemed colleagues in his field, including Dan T. Stinchcomb and Jorge E. Osorio. These collaborations have further enriched his research and have led to significant advancements in the understanding of live attenuated viruses.

Conclusion

O'Neil Wiggan's contributions to the field of virology through his patents and collaborations highlight his role as an innovator in live attenuated virus research. His work continues to pave the way for advancements in vaccine development and viral research.